Min Zhao

Min Zhao


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Reproductive Sciences
Verified
Journal Article
Closed access
MZMin Zhao
Min Zhao
FSF. Shen
F. Shen
YYY. X. Yin
Y. X. Yin
YYY. Y. Yang
Y. Y. Yang
DXD. J. Xiang
D. J. Xiang
QCQ. Chen
Q. Chen

30 May 2012 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YYY. X. Yin
Y. X. Yin
FSF. Shen
F. Shen
HPH. Pei
H. Pei
YDY. Ding
Y. Ding
HZHua Zhao
Hua Zhao
QCQ. Chen
Q. Chen

25 August 2022 in Endocrinology
Verified
Journal Article
Open access
PDF file
CMClaudia Main
Claudia Main
XCXinyue Chen
Xinyue Chen
MZMin Zhao
Min Zhao
LCLawrence W Chamley
Lawrence W Chamley
Qi ChenQi Chen
Qi Chen
It is well known that many factors, including infertility, obesity, type 2 diabetes, and family history of cancer, increase the risk of developing endometrial and ovarian cancer. However, multiparous women are known to have a lower risk of developing either ovarian or endometrial cancer than nonparous women. The lack of ovulation and shifting of sex hormonal balance, with decreased estrogen levels and increased progesterone levels during pregnancy, has traditionally been thought to be the major contributor to this decreased risk. However, in reality, the mechanisms underlying this phenomenon are relatively unknown. Increasing evidence suggests that endocrine factors are unlikely to completely explain the protective effect of pregnancies, and that multiple other nonendocrine mechanisms including fetal antigens and the newly proposed dormant cells hypothesis may also be involved. In this review, we summarize recent evidence and describe the potential underlying mechanisms that may explain how pregnancy protects against the development of ovarian and endometrial cancers in women's later life.

28 June 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YYYongxiang Yin
Yongxiang Yin
MWMan Wu
Man Wu
GNGuiying Nie
Guiying Nie
KWKe Wang
Ke Wang
JWJia Wei
Jia Wei
QCQi Chen
Qi Chen

6 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
YZYi Zhang
Yi Zhang
YTYunhui Tang
Yunhui Tang
XSXinyi Sun
Xinyi Sun
MKMatt Kang
Matt Kang
MZMin Zhao
Min Zhao
Qi ChenQi Chen
Qi Chen
Introduction: Dysfunction of placental development is involved in early pregnancy loss. Senescent changes have been seen in missed miscarriage, one type of pregnancy loss. Extracellular vesicles (EVs) have been widely implicated in the pathogenesis of diseases. In this study, we investigated the protein profiles in placental EVs derived from missed miscarriage in comparison with healthy pregnancy. We also investigated whether cargos packed into EVs are involved in the dysfunctional development of the placenta seen in missed miscarriage. Methods: Proteomic analysis of placental EVs derived from healthy and missed-miscarriage placentae was performed. Three senescence-repair-associated proteins, replication protein A-70 (RPA-70), proteasome activator subunit-4 (PMSE-4), and protein activated kinase-2, (PAK-2) were examined in placental EVs and placentae, and in placental explants that had been treated with or without GW4869, by western blotting and immunohistochemistry. Results: The total number of proteins associated with placental EVs was not different between the two groups. However, there were 106 and 151 abundantly expressed proteins associated with placental micro- or nano-EVs from missed miscarriage in comparison with EVs from controls. Of these abundant proteins, 59 and 81 proteins in placental micro- or nano-EVs, respectively, are associated with DNA damage/repair and cell death/survival. We further found higher levels of three senescence-repair-associated proteins (RPA-70, PMSE-4, and PAK-2) associated with placental EVs, but lower levels of these proteins in missed-miscarriage placentae. Regarding inhibition of EV formation or release by GW4869, we found that the expression of these three proteins was higher in GW4869-treated placental explants from missed miscarriage. Discussion: Our data may suggest that “inadvertently” sorting of cargos and exporting proteins associated with senescence-repair by placental EVs may be associated with the dysfunction of placental development seen in missed miscarriage.

30 April 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
XCXingyu Chen
Xingyu Chen
JSJiayi Sheng
Jiayi Sheng
XSXinyi Sun
Xinyi Sun
GCGeorge Qiaoqi Chen
George Qiaoqi Chen
Qi ChenQi Chen
Qi Chen
Background: The association of complications of pregnancy and the risk of developing gynecological cancer is controversial with the limited study. In this study, we investigated the association of preeclampsia, or gestational diabetes mellitus (GDM), or large for gestational age (LGA), or intrauterine growth restriction (IUGR) and the risk of endometrial or ovarian cancer. Methods: In this case-control study, 189 women with endometrial cancer and 119 women with ovarian cancer were included. 342 women without gynecological cancers were randomly selected as a control group. Data on the history of pregnancy and age at diagnosis of gynecological cancer as well as the use of intrauterine devices (IUDs) were collected. Results: Women with a history of preeclampsia or IUGR did not have an increased risk of developing endometrial or ovarian cancer. While women with a history of GDM or with the delivery of LGA infant increased the risk of developing endometrial cancer but not ovarian cancer. The odds of women with a history of GDM or with the delivery of LGA infant developing endometrial cancer was 2.691 (95% CI: 1.548, 4.3635, p=0.0003), or 6.383 (95% CI: 2.812, 13.68, p<0.0001) respectively, compared to the controls. The odds ratio of women who did not use IUDs developing ovarian cancer was 1.606 (95% CI: 1.057, 2.434), compared to the controls. There was no association of age at first birth and developing endometrial or ovarian cancer. Conclusion: Our observational data suggested that GDM and delivery of an LGA infant are associated with an increased risk of endometrial cancer.